Sho-seiryu-to Suppresses Histamine Signaling at the Transcriptional Level in TDI-Sensitized Nasal Allergy Model Rats

Background: The therapeutic use of Kampo medicine, Sho-seiryu-to (SST) in allergic disorders is well known. As histamine plays a central role in allergic diseases, it is possible that SST affects the allergy-related histamine signaling. In this study, we investigated the effect of SST on allergy-rel...

Full description

Bibliographic Details
Main Authors: Asish Kumar Das, Hiroyuki Mizuguchi, Madoka Kodama, Shrabanti Dev, Hayato Umehara, Yoshiaki Kitamura, Chiyo Matsushita, Noriaki Takeda, Hiroyuki Fukui
Format: Article
Language:English
Published: Elsevier 2009-01-01
Series:Allergology International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893015306651
id doaj-bea322a2edaa447593a6bd248d872cd4
record_format Article
spelling doaj-bea322a2edaa447593a6bd248d872cd42020-11-24T23:04:23ZengElsevierAllergology International1323-89302009-01-01581818810.2332/allergolint.O-07-526Sho-seiryu-to Suppresses Histamine Signaling at the Transcriptional Level in TDI-Sensitized Nasal Allergy Model RatsAsish Kumar Das0Hiroyuki Mizuguchi1Madoka Kodama2Shrabanti Dev3Hayato Umehara4Yoshiaki Kitamura5Chiyo Matsushita6Noriaki Takeda7Hiroyuki Fukui8Departments of Molecular Pharmacology, The University of Tokushima Graduate School, Tokushima, Japan.Departments of Molecular Pharmacology, The University of Tokushima Graduate School, Tokushima, Japan.Departments of Molecular Pharmacology, The University of Tokushima Graduate School, Tokushima, Japan.Departments of Molecular Pharmacology, The University of Tokushima Graduate School, Tokushima, Japan.Departments of Molecular Pharmacology, The University of Tokushima Graduate School, Tokushima, Japan.Otolaryngology, Institute of Health-Biosciences, The University of Tokushima Graduate School, Tokushima, Japan.Departments of Molecular Pharmacology, The University of Tokushima Graduate School, Tokushima, Japan.Otolaryngology, Institute of Health-Biosciences, The University of Tokushima Graduate School, Tokushima, Japan.Departments of Molecular Pharmacology, The University of Tokushima Graduate School, Tokushima, Japan.Background: The therapeutic use of Kampo medicine, Sho-seiryu-to (SST) in allergic disorders is well known. As histamine plays a central role in allergic diseases, it is possible that SST affects the allergy-related histamine signaling. In this study, we investigated the effect of SST on allergy-related histamine signaling in the nasal mucosa of toluene 2, 4-diisocyanate (TDI)-sensitized nasal allergy model rats. Methods: Six-week-old male, Brown Norway rats were sensitized for 2 weeks with 10 μl of 10% TDI, and after a 1 week interval, provocation was initiated with the same amount of TDI. SST (0.6 g/rat) was given orally 1 hour before TDI treatment began for a period of 3 weeks. Nasal symptoms were scored for 10 minutes immediately after TDI-provocation. The genes expression in nasal mucosa was determined using real-time quantitative RT-PCR. Results: SST significantly suppressed TDI-induced nasal allergy-like symptoms. TDI provocation showed a significant up-regulation of histamine H1 receptor (H1R) and histidine decarboxylase (HDC) gene expressions. Prolonged pre-treatment of SST significantly suppressed the mRNA levels of H1R and HDC that was up-regulated by TDI. SST also suppressed TDI-induced interleukin (IL)-4 and IL-5 mRNA elevation. However, SST showed no significant effect for TDI-induced mRNA elevation of IL-13. Conclusions: These results demonstrate that SST alleviates nasal symptoms by the inhibition of histamine signaling through suppression of TDI-induced H1R and HDC gene up-regulation. SST also suppresses cytokine signaling through suppression of IL-4 and IL-5 gene expression. Suppression of histamine signaling may be a novel mechanism of SST in preventing allergic diseases.http://www.sciencedirect.com/science/article/pii/S1323893015306651allergygene expressionhistamine H1 receptorshistamine signalinghistidine decarboxylaseTh2 cytokines
collection DOAJ
language English
format Article
sources DOAJ
author Asish Kumar Das
Hiroyuki Mizuguchi
Madoka Kodama
Shrabanti Dev
Hayato Umehara
Yoshiaki Kitamura
Chiyo Matsushita
Noriaki Takeda
Hiroyuki Fukui
spellingShingle Asish Kumar Das
Hiroyuki Mizuguchi
Madoka Kodama
Shrabanti Dev
Hayato Umehara
Yoshiaki Kitamura
Chiyo Matsushita
Noriaki Takeda
Hiroyuki Fukui
Sho-seiryu-to Suppresses Histamine Signaling at the Transcriptional Level in TDI-Sensitized Nasal Allergy Model Rats
Allergology International
allergy
gene expression
histamine H1 receptors
histamine signaling
histidine decarboxylase
Th2 cytokines
author_facet Asish Kumar Das
Hiroyuki Mizuguchi
Madoka Kodama
Shrabanti Dev
Hayato Umehara
Yoshiaki Kitamura
Chiyo Matsushita
Noriaki Takeda
Hiroyuki Fukui
author_sort Asish Kumar Das
title Sho-seiryu-to Suppresses Histamine Signaling at the Transcriptional Level in TDI-Sensitized Nasal Allergy Model Rats
title_short Sho-seiryu-to Suppresses Histamine Signaling at the Transcriptional Level in TDI-Sensitized Nasal Allergy Model Rats
title_full Sho-seiryu-to Suppresses Histamine Signaling at the Transcriptional Level in TDI-Sensitized Nasal Allergy Model Rats
title_fullStr Sho-seiryu-to Suppresses Histamine Signaling at the Transcriptional Level in TDI-Sensitized Nasal Allergy Model Rats
title_full_unstemmed Sho-seiryu-to Suppresses Histamine Signaling at the Transcriptional Level in TDI-Sensitized Nasal Allergy Model Rats
title_sort sho-seiryu-to suppresses histamine signaling at the transcriptional level in tdi-sensitized nasal allergy model rats
publisher Elsevier
series Allergology International
issn 1323-8930
publishDate 2009-01-01
description Background: The therapeutic use of Kampo medicine, Sho-seiryu-to (SST) in allergic disorders is well known. As histamine plays a central role in allergic diseases, it is possible that SST affects the allergy-related histamine signaling. In this study, we investigated the effect of SST on allergy-related histamine signaling in the nasal mucosa of toluene 2, 4-diisocyanate (TDI)-sensitized nasal allergy model rats. Methods: Six-week-old male, Brown Norway rats were sensitized for 2 weeks with 10 μl of 10% TDI, and after a 1 week interval, provocation was initiated with the same amount of TDI. SST (0.6 g/rat) was given orally 1 hour before TDI treatment began for a period of 3 weeks. Nasal symptoms were scored for 10 minutes immediately after TDI-provocation. The genes expression in nasal mucosa was determined using real-time quantitative RT-PCR. Results: SST significantly suppressed TDI-induced nasal allergy-like symptoms. TDI provocation showed a significant up-regulation of histamine H1 receptor (H1R) and histidine decarboxylase (HDC) gene expressions. Prolonged pre-treatment of SST significantly suppressed the mRNA levels of H1R and HDC that was up-regulated by TDI. SST also suppressed TDI-induced interleukin (IL)-4 and IL-5 mRNA elevation. However, SST showed no significant effect for TDI-induced mRNA elevation of IL-13. Conclusions: These results demonstrate that SST alleviates nasal symptoms by the inhibition of histamine signaling through suppression of TDI-induced H1R and HDC gene up-regulation. SST also suppresses cytokine signaling through suppression of IL-4 and IL-5 gene expression. Suppression of histamine signaling may be a novel mechanism of SST in preventing allergic diseases.
topic allergy
gene expression
histamine H1 receptors
histamine signaling
histidine decarboxylase
Th2 cytokines
url http://www.sciencedirect.com/science/article/pii/S1323893015306651
work_keys_str_mv AT asishkumardas shoseiryutosuppresseshistaminesignalingatthetranscriptionallevelintdisensitizednasalallergymodelrats
AT hiroyukimizuguchi shoseiryutosuppresseshistaminesignalingatthetranscriptionallevelintdisensitizednasalallergymodelrats
AT madokakodama shoseiryutosuppresseshistaminesignalingatthetranscriptionallevelintdisensitizednasalallergymodelrats
AT shrabantidev shoseiryutosuppresseshistaminesignalingatthetranscriptionallevelintdisensitizednasalallergymodelrats
AT hayatoumehara shoseiryutosuppresseshistaminesignalingatthetranscriptionallevelintdisensitizednasalallergymodelrats
AT yoshiakikitamura shoseiryutosuppresseshistaminesignalingatthetranscriptionallevelintdisensitizednasalallergymodelrats
AT chiyomatsushita shoseiryutosuppresseshistaminesignalingatthetranscriptionallevelintdisensitizednasalallergymodelrats
AT noriakitakeda shoseiryutosuppresseshistaminesignalingatthetranscriptionallevelintdisensitizednasalallergymodelrats
AT hiroyukifukui shoseiryutosuppresseshistaminesignalingatthetranscriptionallevelintdisensitizednasalallergymodelrats
_version_ 1725630788644372480